Table 3.
Relationship between age, duration of HIV infection and antiretroviral therapy (in years) and cardiovascular mortality risk score classification
| Variables (years) | Risk score | |||||
|---|---|---|---|---|---|---|
| < 5.00% | 5.00–9.9% | 10.00–19.9% | 20.00–29.9% | > 30.00% | P-valuei | |
| Age | ||||||
| N | 75 | 26 | 23 | 9 | 11 | |
| Mean (SD) | 37.52 (4.50) | 44.47 (5.52) | 48.05 (5.64) | 51.67 (4.36) | 57.82 (6.27) | Overall: < 0.001 |
| Duration of HIV infection | ||||||
| N | 41 | 16 | 12 | 7 | 5 | |
| Median (P25–P75) | 6.64 (3.63–9.86) | 8.11 (4.46–11.07) | 6.91 (5.11–8.02) | 7.41 (2.20–12.10) | 11.51 (7.11–11.69) | 0.684 |
| Duration since ART initiation | ||||||
| N | 75 | 26 | 23 | 9 | 11 | |
| Median (P25–P75) | 6.37 (4.44–9.06) | 8.26 (4.64–11.01) | 6.19 (4.78–7.31) | 7.39 (7.11–11.85) | 8.09 (6.83–10.55) | 0.119 |
iOne-way analysis of variance ANOVA with Bonferroni correction for multiple testing